|
You
are here: Home: BCU 5|2001: Editor's Note: Special publications
Select
Publications
Early Breast Cancer Trialists’ Collaborative Group.Tamoxifen
for early breast cancer: An overview of the randomised trials.
Lancet 1998;351:1451-1467. Abstract
Eifel P et al. National Institutes of Health Consensus Development
Conference Statement:Adjuvant therapy for breast cancer, November
1-3, 2000. J Natl Cancer Inst 2001;93(13):979-89. Abstract
Mouridsen H et al. Superior efficacy of letrozole versus tamoxifen
as first-line therapy for postmenopausal women with advanced breast
cancer: Results of a phase III study of the International Letrozole
Breast Cancer Group. J Clin Oncol 2001 May;19(10):2596-606.
Abstract
Nabholtz JM et al.Anastrozole is superior to tamoxifen as first-line
therapy for advanced breast cancer in postmenopausal women:Results
of a North American multicenter randomized trial.Arimidex Study
Group. J Clin Oncol 2000;18(22):3758-67. Abstract
Yao K et al. Antitumor action of physiological estradiol on tamoxifen-stimulated
breast tumors grown in athymic mice. Clin Cancer Res
2000;6(5):2028-36. Abstract
Return
|
|
